CClinicalTrials.gg
RecruitingNCT07499024Updated Apr 29, 2026

Evaluation of the Diagnostic Performance of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) Score for Assessing the Risk of Testicular Torsion in Adult Patients Presenting to the Emergency Department With Scrotal Pain - A Prospective Observational Study

An observational study in Testicular Torsion, Acute Scrotum and Scrotal Pain, sponsored by University Hospital, Linkoeping. Recruiting at 1 site in Sweden. Open to male participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by University Hospital, Linkoeping · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

This prospective multicenter observational study aims to evaluate the diagnostic accuracy of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) score in adult patients presenting with acute scrotal pain in Swedish Emergency Departments.

The TWIST score is a clinical decision tool originally validated in pediatric populations to stratify patients into low, intermediate, and high risk for testicular torsion. The study will include men aged 18-40 years presenting with scrotal pain or symptoms suggestive of torsion. Patients with scrotal trauma, symptom duration over one week, previous testicular surgery, or inability to give informed consent in Swedish will be excluded.

Participants' clinical findings will be recorded on a standardized form, and the TWIST score will be calculated. Management will follow standard clinical practice independently of the study. Primary outcome is the diagnostic accuracy of the TWIST score to rule out testicular torsion in low-risk patients (TWIST 0-2). Secondary outcomes include diagnosis of torsion within 30 days, time to surgery, patient-reported pain, number of Doppler ultrasounds performed, and the potential reduction in unnecessary imaging.

The study will be conducted at multiple Swedish sites, including Linköping University Hospital, under oversight by the Swedish Ethical Review Authority (Etikprövningsmyndigheten, decision number 2025-07400-01). The results aim to inform clinical practice by providing a validated decision-support tool for adult patients with suspected testicular torsion, potentially improving patient outcomes and resource utilization.

Read the detailed description

Acute scrotal pain is a common presentation in Emergency Departments, but the diagnosis of testicular torsion (TT) is relatively rare. Prompt identification is crucial because TT requires urgent surgical intervention to preserve testicular viability. Delays in diagnosis, particularly due to unnecessary imaging or non-standardized clinical assessment, may result in testicular loss.

The TWIST (Testicular Workup for Ischemia and Suspected Torsion) score is a clinical decision tool developed and validated in pediatric populations to stratify risk of TT based on five clinical features: testicular swelling, hard testis, high-riding testis, absent cremasteric reflex, and nausea/vomiting. Adult validation is limited, and no large-scale multicenter study has evaluated its performance in adult Emergency Department settings in Sweden.

This study will prospectively collect structured clinical data from adult patients aged 18-40 years presenting with scrotal pain at participating Swedish EDs. The TWIST score will be calculated from documented clinical findings. The study does not influence clinical management; patients will receive standard care, including imaging or surgical intervention as deemed appropriate by treating clinicians.

Primary objectives focus on the diagnostic accuracy of TWIST for ruling out TT in low-risk patients, while secondary objectives include assessment of the score in identifying high-risk patients, measurement of time to surgery, evaluation of pain scores, and analysis of imaging utilization. Data will also be linked to the Swedish Perioperative Register (SPOR) for outcomes such as surgery performed, complications, and final diagnoses.

The study is designed to evaluate whether structured use of TWIST can support evidence-based, standardized risk stratification in adults, potentially improving patient outcomes, streamlining resource use, and reducing unnecessary delays in diagnosis and treatment. Ethical oversight is provided by the Swedish Ethical Review Authority (Etikprövningsmyndigheten, decision 2025-07400-01).

02

Conditions studied

  • Testicular Torsion
  • Acute Scrotum
  • Scrotal Pain

Keywords

  • Testicular Torsion
  • Acute Scrotum
  • Testicular Workup for Ischemia and Suspected Torsion (TWIST)
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult men aged 18-40 years presenting to participating Emergency Departments in Sweden with acute scrotal pain or scrotal symptoms suggestive of testicular torsion. Patients with trauma-related scrotal pain, symptom duration longer than one week, previous testicular surgery, or inability to provide informed consent are excluded. The study aims to evaluate the diagnostic accuracy of the TWIST score in a real-world adult ED population.

Inclusion criteria

  • Male patients aged 18-40 years

Presenting to the Emergency Department with acute scrotal pain or scrotal symptoms

Suspicion of testicular torsion before clinical assessment

Exclusion criteria

Exclusion Criteria:

  • Scrotal pain or symptoms caused by trauma

Symptom duration > 1 week

History of testicular surgery

Inability to provide informed consent (e.g., language barrier or cognitive limitation)

04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Adult ED Patients with Acute Scrotal Pain

    All participants are assessed according to routine clinical care in the Emergency Department. The TWIST score is calculated from standard clinical findings but does not influence management; decisions regarding imaging or surgery follow usual clinical practice. Data on symptoms, TWIST score components, and outcomes (including surgical confirmation of testicular torsion) are collected prospectively.

05

What researchers measure

Primary outcomes

  1. Diagnostic Accuracy of the TWIST Score (Low-Risk Group)

    Number and proportion of adult patients with a low-risk TWIST score (0-2) who are confirmed not to have testicular torsion based on surgical exploration or follow-up within 30 days. This measures the sensitivity of the TWIST score to safely rule out torsion.

    Time frame: Up to 30 days from ED visit

Secondary outcomes

  1. Time to exploration

    Time in hours from patient arrival in the Emergency Department to surgical intervention for suspected testicular torsion.

    Time frame: 30 days from ED visit

  2. Testicular torsion

    Number of testicular torsions found up to 30 days from ED visit

    Time frame: 30 days from inclusion

  3. Pain at study inclusion

    Pain at inclusion to the study measured by NRS

    Time frame: Up to one hour from inclusion in the study.

  4. Use of Ultrasound

    If ultrasound was used during the Emergency Department visit

    Time frame: Up to 48 hours from inclusion or ED discharge, whichever comes first

06

Study locations

1 of 1 sites recruiting
  • Linköping University Hospital, ED
    Linköping, Östergötland County 58185, Sweden
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — The study will collect sensitive health data from adult patients with acute scrotal pain. Due to patient privacy and data protection regulations, individual participant-level data will not be shared outside the research team.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07499024
Lead sponsor
University Hospital, Linkoeping
Collaborators
Linkoeping University
Responsible party
Daniel Wilhelms (MD,PHD, University Hospital, Linkoeping) — Principal investigator
First posted
Mar 27, 2026
Start date
Feb 1, 2026
Primary completion
Jan 31, 2028 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Apr 29, 2026

Study contacts

Jens Wretborn, MD, PhD
Contact
jens.wretborn@liu.se
+461030000
Jens Wretborn, MD, PhD
principal investigator · Linkoeping University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion